131 related articles for article (PubMed ID: 11891483)
1. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
Ivancevic V; Huic D; Wolter A; Munz DL
Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
[TBL] [Abstract][Full Text] [Related]
2. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab' fragment in patients with previous joint surgery.
Ivanćević V; Perka C; Hasart O; Sandrock D; Munz DL
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):547-51. PubMed ID: 11914895
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
Huić D; Ivancević V; Richter WS; Munz DL
J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific bowel activity in imaging inflammation with Tc-99m labelled monoclonal anti-NCA-90 Fab' fragment MN3.
Ivancević V; Wolter A; Munz DL
Nuklearmedizin; 2001 Jun; 40(3):71-4. PubMed ID: 11475075
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-labeled chimeric anti-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging.
Sarwar M; Higuchi T; Tomiyoshi K; Inoue T; Oriuchi N; Kbalil A; Alyafei S; Sakahara H; Chung JK; Endo K
Radiat Med; 1998; 16(5):391-7. PubMed ID: 9862166
[TBL] [Abstract][Full Text] [Related]
6. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
Krause T; Reinhardt M; Nitzsche E; Moser E
Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
Chung JK; Yeo J; Lee DS; Park S; Lee MC; Kim BK; Koh CS
J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
10. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
Choi CW; Chung JK; Lee DS; Lee MC; Chung HK; Kim BK; Koh CS
Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
[TBL] [Abstract][Full Text] [Related]
11. 99mTC-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis.
Gratz S; Raddatz D; Hagenah G; Behr T; Béhé M; Becker W
Int J Cardiol; 2000 Aug; 75(1):75-84. PubMed ID: 11054510
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
Matthies A; Reinhardt M; Palmedo H; Ezziddin S; Abramowski B; Kuhn W; Biersack HJ; von Mallek D
Cancer Invest; 2005; 23(2):119-22. PubMed ID: 15813503
[TBL] [Abstract][Full Text] [Related]
14. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W
Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
Zoeller G; Sandrock D; Munz DL; Ringert RH
Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis.
Thelen MH; Eschmann SM; Moll-Kotowski M; Dopfer R; Bares R
J Nucl Med; 1998 Jun; 39(6):1033-5. PubMed ID: 9627340
[TBL] [Abstract][Full Text] [Related]
19. 99Tcm-LL1: a potential new bone marrow imaging agent.
Juweid M; Dunn RM; Sharkey RM; Rubin AD; Hansen HJ; Goldenberg DM
Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow immunoscintigraphy in haematological patients with pancytopenia: preliminary results.
Huić D; Ivancević V; Aurer I; Dodig D; Nemet D; Labar B; Poropat M; Munz DL
Nucl Med Commun; 2002 Aug; 23(8):757-63. PubMed ID: 12124481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
